Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lucas Henrique Olandoski Erbano"'
Autor:
Bruna Olandoski Erbano, Nicolle Amboni Schio, Renato Delascio Lopes, Tiago Costa Bignoto, Marcia Olandoski, Raquel Silva Brito da Luz, Guilherme Dagostin de Carvalho, Lucas Henrique Olandoski Erbano, Auristela Isabel de Oliveira Ramos, Fausto Feres, José Rocha Faria Neto, Cristina Pellegrino Baena, Dimytri Alexandre de Alvim Siqueira
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 120, Iss 7 (2023)
Resumo Fundamento A extensão do dano cardíaco associada à estenose aórtica tem importantes implicações prognósticas após a substituição da valva aórtica transcateter (TAVR). Contudo, ainda não está claro qual é o papel da insuficiência
Externí odkaz:
https://doaj.org/article/660ccbd13436458ab8ccdb754bf45188
Autor:
Viviane Bernardes de Oliveira Chaiben, Thabata Baechtold da Silveira, Murilo Henrique Guedes, João Pedro de Almeida Fernandes, João Henrique Fregadolli Ferreira, Julianna Beltrão, Giovanna Foltran Leal, Lucas Henrique Olandoski Erbano, Natasha Ludmila Bosch, Roberto Pecoits Filho, Thyago Proença de Moraes, Cristina Pellegrino Baena
Publikováno v:
Brazilian Journal of Nephrology, Iss 0 (2018)
ABSTRACT Introduction: The prevalence of chronic kidney disease (CKD) is increasing, with a potential impact in the risk of acceleration of dementia. The potential association between glomerular filtration rate (eGFR) and cognitive performance was sc
Externí odkaz:
https://doaj.org/article/ca8cafa3005b44ebb7b35613221c172a
Autor:
Bruce M. Robinson, Jarcy Zee, Ronald L. Pisoni, Andre G. Palone, Thyago Proença de Moraes, Roberto Pecoits-Filho, Camila Roginski Guetter, Murilo Guedes, Cristina Pellegrino Baena, Lucas Henrique Olandoski Erbano
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-15 (2020)
BMC Nephrology
BMC Nephrology
Background The impact of anemia treatment with erythropoietin stimulating agents (ESA) on health-related quality of life (HRQOL) in chronic kidney disease (CKD) patients is controversial, particularly regarding optimal hemoglobin (Hb) target ranges.
Autor:
Murilo Guedes, Bruce M. Robinson, Palone Ag, Cristina Pellegrino Baena, R. Pisoni, Lucas Henrique Olandoski Erbano, R. Pecoits-Filho, Camila Roginski Guetter, Jarcy Zee, Thyago Proença de Moraes
Background: The impact anemia treatment with erythropoietin stimulating agents (ESA) on health-related quality of life (HRQOL) in chronic kidney disease (CKD) patients is controversial, particularly regarding optimal hemoglobin (Hb) target ranges.Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e16fa338f7ae62deed7e7792c6dcc7e8
https://doi.org/10.21203/rs.2.24371/v1
https://doi.org/10.21203/rs.2.24371/v1
Autor:
Viviane B. de Oliveira Chaiben, Natasha Ludmila Bosch, João Henrique Fregadolli Ferreira, João Pedro de Almeida Fernandes, Julianna Rodrigues Beltrão, Cristina Pellegrino Baena, Thyago Proença de Moraes, Giovanna Foltran Leal, Thabata Baechtold da Silveira, Roberto Pecoits Filho, Murilo Guedes, Lucas Henrique Olandoski Erbano
Publikováno v:
Brazilian Journal of Nephrology, Iss 0 (2018)
Brazilian Journal of Nephrology, Issue: ahead, Published: 13 SEP 2018
Brazilian Journal of Nephrology, Volume: 41, Issue: 2, Pages: 200-207, Published: 13 SEP 2018
Brazilian Journal of Nephrology v.41 n.2 2019
Jornal Brasileiro de Nefrologia
Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
Brazilian Journal of Nephrology, Issue: ahead, Published: 13 SEP 2018
Brazilian Journal of Nephrology, Volume: 41, Issue: 2, Pages: 200-207, Published: 13 SEP 2018
Brazilian Journal of Nephrology v.41 n.2 2019
Jornal Brasileiro de Nefrologia
Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
Introduction: The prevalence of chronic kidney disease (CKD) is increasing, with a potential impact in the risk of acceleration of dementia. The potential association between glomerular filtration rate (eGFR) and cognitive performance was scarcely st